Commercialization: Page 92

PharmaVoice Team/PharmaVoice

On the Calendar

March 1718 3rd Imaging in Preclinical &Clinical Drug Development San Diego For more information, contact Vivian Frankel, GTCBio, at 6262566405, email [email protected], or visit gtcbio.com. March 1718 The Inaugural U.S.Conference on Comparator Studies Doubletree Hotel,Philadelphia For...
By PharmaVoice Team • March 2, 2008
PharmaVoice Team/PharmaVoice

E-Media

NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES Edge Dynamics has added a flexible desktop module within its Demand Management Suite that offers lifesciences manufacturers a way to easily monitor and analyze channel activity data for their products. The Edge Dynamics Demand Dash...
By PharmaVoice Team • March 2, 2008
PharmaVoice Team/PharmaVoice

What's New

WHAT’S NEW NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES HealthEd Group has launched HealthEd Encore, which operates as a standalone agency, in response to increas ing client demand for educational patient marketing campaigns. HealthEd Encore offers a fullrange of ser vices, including c...
By PharmaVoice Team • March 2, 2008
PharmaVoice Team/PharmaVoice

PharmaTrax

Best practices in planning and targeting and conducting office calls, as well as management of relationships, samples, programs, and salesforces are explored. These include the use of automated for mulary data and thoughtleader information to develop sales messages that anticipate formulary restr...
By PharmaVoice Team • March 2, 2008
PharmaVoice Team/PharmaVoice

For Art's Sake

There have been more than a few occasions when I felt I needed nothing short of a magic spell to get a client to run with an unconventional concept — the one that’s wonderfully unique while completely hitting the mark. The team at GSWWorldwide has done just that with their new “Itchcraft”campaign...
By PharmaVoice Team • March 2, 2008
PharmaVoice Team/PharmaVoice

The Fourth Tier: Tighter Control of Specialty Drugs

Managed MARKETS Managed care organizations are tackling the rising costs and expanding use of specialty products. Specialty drugs, injectable biologics, and other highercost drugs that require close supervision and monitoring are the fastest growing segment of the overall pharmaceutical space. Th...
By Denise Myshko • March 2, 2008
PharmaVoice Team/PharmaVoice

A Strategy for Pharma Diversification

In response to myriad challenges and with the hope of renewing double digit growth, the question becomes whether pharmaceutical firms should hold on to a pure pharmaceutical business model or embrace a more aggressive diversification strategy, says Roger Fournier, a senior executive working at a ...
By PharmaVoice Team • March 2, 2008
PharmaVoice Team/PharmaVoice

Ted Schroeder — A Thoughtful Note

BY KIM RIBBINK A THOUGHTFUL ote considered approach to leadership has helped Ted Schroeder guide his team through ups and downs and set Cadence Pharmaceuticals on a defined path, one in which a vibrant culture and strong core values are the keys to its longterm success. N A A Photography by natha...
By Kim Ribbink • March 2, 2008
PharmaVoice Team/PharmaVoice

A Woman's Heart

Women are six times more likely to die from heart attacks than breast cancer. Car diovascular diseases (CVD), particularly coronary heart disease (CHD) and stroke, remain the leading causes of death of women in America and most developed coun tries, with almost 39% of all female deaths in the Uni...
By Cynthia Borda • March 2, 2008
PharmaVoice Team/PharmaVoice

Climbing the Corporate Lattice

BY KIM RIBBINK executive search firm. “People need to be more prepared to work in a number of different companies or settings, including not just pharma but also specialty pharma and startup biotech.” This means there is tremendous movement in the industry, which presents challenges for companies...
By PharmaVoice Team • March 2, 2008
PharmaVoice Team/PharmaVoice

PharmaTrax

Medicare Part D Results in INCREASED USE OF GENERIC DRUGS Generics accounted for more than half the drugs dispensed under Medicare’s Part D in its first six months of availability from January through June 2006. According to Generic Drug Utilization in the Medicare Part D Program, a report from t...
By PharmaVoice Team • Jan. 30, 2008
PharmaVoice Team/PharmaVoice

PharmaOutlet

For what seems like years, I have been attending continuing medical education (CME) meeting after CME meeting, reading article after article, listening to everyone qualified to have an opinion sharing his or her view. The topics and themes have remained the same. Quality improvement (QI) or perfo...
By Rick Kennison • Jan. 30, 2008
PharmaVoice Team/PharmaVoice

HBA Leadership Conference

5th Annual HBA Leadership Conference 1 More than 500 industry leaders representing the Healthcare Businesswomen’s Association’s 10 chapters and three affiliates met in Washington,D.C., for an inspirational two?day conference, featuring a distinguished lineup of speakers and sessions. 2 4 7 1. Int...
By PharmaVoice Team • Jan. 30, 2008
PharmaVoice Team/PharmaVoice

Developing a Formulary Formula

Managed MARKETS Experts on this Topic Sean Brandle. National Rx Practice Leader, The Segal Company, New York; The Segal Company is a private employee-owned actuarial and consulting firm. For more information, visit segalco.com. Larry Olson. VP and Practice Leader, Payer Markets, TNS Healthcare, N...
By PharmaVoice Team • Jan. 30, 2008
PharmaVoice Team/PharmaVoice

Managing Investigator Initiated Trials

Investigator initiated trials (IITs) can be a valuable part of a pharmaceutical or medical device manufacturer’s marketing claims arsenal, according to Rita Numerof, Ph.D., president, and Mark Morgan, M.S., senior business analyst, at Numerof & Associates Inc. The two contend that IITs are re...
By PharmaVoice Team • Jan. 30, 2008
PharmaVoice Team/PharmaVoice

Conquering the Divide — Joseph Pieroni

BY KIM RIBBINK Drawn initially to the lab as a medicinal chemist,then to the business side of pharma research, Joseph P. Pieroni has been able to straddle the often divided worlds of research and marketing seamlessly. This combination of skills and interests is great news for Daiichi Sankyo Inc.,...
By Kim Ribbink • Jan. 30, 2008
PharmaVoice Team/PharmaVoice

MSLs: Evolution of Skills

The intent of the first MSL role, created in 1967 by the Upjohn Company, was to create a position within the pharmaceutical company that could interact with academiabased physicians and researchers. In the 1970s, the trend grew, with other companies mostly implementing MSL hir ing from within the...
By Robin Robinson • Jan. 30, 2008
PharmaVoice Team/PharmaVoice

Controlling the Message in Cyber Space and Time

Keeping Up With the 2.0 Joneses To maintain a competitive edge in today’s crowded environment,most experts believe the industry needs to step up its 2.0 practices or get left behind in a swirl of networking dust. Not only may early adopters get a marketing leg up on companies that choose to drag ...
By PharmaVoice Team • Jan. 29, 2008
PharmaVoice Team/PharmaVoice

Let the Games Begin

The influx of Gen-Xers and Yers into today’s workforce is pushing the industry’s conservative management leaders to play more games. Cutting-edge, fast-paced, highly competitive computer-based simulations and games designed to educate as they engage are gaining traction in the industry. The influ...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Talent Pool

Executive Appointments and Promotions Pharma POOL Aaron D. Berg Mark A. Glickman Oscient Names VPs to Head Key Growth Functions Oscient Pharmaceuticals, Waltham, Mass., has appointed two senior leaders with extensive cardiovascular experience. Aaron D. Berg has been named VP of marketing and Mark...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Salesforces

By Taren Grom, Editor A new sales model will emerge that uses sophisticated selling techniques, technologies, and education. The Salesforce of the Future In the future, the salesforce army of today will be but a distant memory as a new sales model emerges that uses sophisticated selling technique...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Marketing

Marketers are changing their messages in light of a DTC pullback and a rising tide of nontraditional outlets and tools. Industry experts are divided as to how rapidly pharmaceutical marketers will embrace new and emerging technologies to capitalize on the number of opportunities new media afford....
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Crystal Ball

Industry experts identify the top trends they expect to shape the industry. We asked our industry experts to identify the top trends that they expect to shape the industry in the coming year and beyond. Some of their responses may surprise you; others may already be on your radar. You may agree w...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Marketplace

Featured Product and Service Showcases AmerisourceBergen Specialty Group Berkery Noyes Biltmore Technoligies Inc. Compass Healthcare Communications Criterium Inc. HealthEd JUICE Pharma Advertising Kinect Medidata Solutions Worldwide Qi, part of CommonHealth SK&A Inf...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Strategy Drives Partnerships in Closed Loop Marketing

Strategy Drives Partnerships in Closed Loop Marketing Closed loop marketing (CLM) is defined as the ability to optimize customer communications by capturing initial brand interactions and measuring for marketing effectiveness and ROI, and then refining the ...
By PharmaVoice Team • Jan. 2, 2008